Top

Journal of Neurology

Published in:

01-10-2011 | Letter to the Editors

No evidence for an association between genetic variation at the SERPINI1 locus and ischemic stroke

Authors: A. Tjärnlund-Wolf, S. Olsson, K. Jood, C. Blomstrand, C. Jern

Published in: Journal of Neurology | Issue 10/2011

Excerpt

Dear Sirs, …

(1995) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333:1581–1587

Teesalu T, Kulla A, Simisker A, Siren V, Lawrence DA, Asser T, Vaheri A (2004) Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 92:358–368PubMed

Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A (2000) Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002–1012PubMedCrossRef

Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50:673–678PubMedCrossRef

Tsirka SE, Gualandris A, Amaral DG, Strickland S (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340–344PubMedCrossRef

Benchenane K, Lopez-Atalaya JP, Fernandez-Monreal M, Touzani O, Vivien D (2004) Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci 27:155–160PubMedCrossRef

Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228–231PubMedCrossRef

Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533–1540PubMed

Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731–737PubMedCrossRef

10.

Polavarapu R, Gongora MC, Yi H, Ranganthan S, Lawrence DA, Strickland D, Yepes M (2007) Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. Blood 109:3270–3278PubMedCrossRef

11.

Yepes M, Sandkvist M, Wong MK, Coleman TA, Smith E, Cohan SL, Lawrence DA (2000) Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96:569–576PubMed

12.

Cinelli P, Madani R, Tsuzuki N, Vallet P, Arras M, Zhao CN, Osterwalder T, Rulicke T, Sonderegger P (2001) Neuroserpin a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci 18:443–457PubMedCrossRef

13.

Cole JW, Naj AC, O’Connell JR, Stine OC, Sorkin JD, Wozniak MA, Stern BJ, Yepes M, Lawrence DA, Reinhart LJ, Strickland DK, Mitchell BD, Kittner SJ (2007) Neuroserpin polymorphisms and stroke risk in a biracial population: the stroke prevention in young women study. BMC Neurol 7:37PubMedCrossRef

14.

Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C (2005) Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke 36:1383–1387PubMedCrossRef

15.

Olsson S, Jood K, Blomstrand C, Jern C (2010) Genetic variation on chromosome 9p21 shows association with the ischaemic stroke subtype large-vessel disease in a Swedish sample aged ≤70. Eur J Neurol 18:365–367CrossRef

Title: No evidence for an association between genetic variation at the SERPINI1 locus and ischemic stroke
Authors: A. Tjärnlund-Wolf
S. Olsson
K. Jood
C. Blomstrand
C. Jern
Publication date: 01-10-2011
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 10/2011
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6022-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

No evidence for an association between genetic variation at the SERPINI1 locus and ischemic stroke

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2011

Life-threatening bradycardia after bilateral paramedian thalamic and midbrain infarction

Improving power to detect disease progression in multiple sclerosis through alternative analysis strategies

Elevated serum level of interleukin-32α in the patients with myasthenia gravis

Multiplex PCR for rapid diagnosis of tuberculous meningitis

Evaluation of the smooth pursuit tests in multiple sclerosis patients

Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials